Pei-Ming Yang

Associate Professor

https://orcid.org/0000-0002-4004-2518

Emailyangpm@tmu.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

2006, Ph.D. (Life Science), National Tsing Hua University
2000, B.S. (Life Science), National Tsing Hua University

Experience

2019- Associate Professor, The Ph.D. Program for Cancer Biology and Drug Discovery, Taipei Medical University
2018- Associate Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
2016-2018 Associate Professor, The Ph.D. Program for Cancer Biology and Drug Discovery, Taipei Medical University
2012-2016 Assistant Professor, The Ph.D. Program for Cancer Biology and Drug Discovery, Taipei Medical University
2007-2009 Postdoctoral fellow, National Taiwan University College of Medicine

Awards

2012 Young Investigator Award, The Pharmacological Society in Taiwan

Research Interests

Cancer Biology
Pharmacology
Epigenetics

URL

Fingerprint

Dive into the research topics where Pei-Ming Yang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Active
12 Finished

抑制site-1蛋白酶引發肝癌細胞自我吞噬之研究
Yang, P.
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
透過老藥新用策略來開發以Stathmin 1為標靶之抗肝癌新藥
Yang, P.
3/1/20 → 2/28/21
Project: C - Project of Alliance › n - Yuan's General Hospital
長鏈非編碼核糖核酸LncHIFCAR/MIR31HG調控的中心網絡在胰臟癌的轉譯研究-探討MIR31HG 調控胰臟癌EMT 及藥物治療反應之作用
Yang, P.
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
探討miR-21調控大腸直腸癌細胞 TET1/5- hydroxymethylcytosine表現對其化療反應之關聯(2/3)(相對補助)
Yang, P.
8/1/16 → 7/31/17
Project: A - Government Institution › f - Other (Funded by Government)
不同APC基因狀態大腸直腸癌患者藥物治療之抗藥性機轉研究-探討miR-21調控大腸直腸癌細胞TET1/5-hydroxymethylcytosine表現對其化療反應之關聯(3/3)
Yang, P.
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology

3945 Citations
18 h-Index
50 Article
2 Comment/debate
2 Review article
1 Editorial

Bioinformatics data mining repurposes the JAK2 (Janus kinase 2) inhibitor fedratinib for treating pancreatic ductal adenocarcinoma by reversing the KRAS (kirsten rat sarcoma 2 viral oncogene homolog)-driven gene signature
Liu, L. W., Hsieh, Y. Y. & Yang, P. M., Sep 16 2020, In : Journal of Personalized Medicine. 10, 3, p. 1-17 17 p., 130.
Research output: Contribution to journal › Article › peer-review

Open Access
Characterizing the Relapse Potential in Different Luminal Subtypes of Breast Cancers with Functional Proteomics
Lin, T. Y., Wang, P. W., Huang, C. H., Yang, P. M. & Pan, T. L., Sep 1 2020, In : International journal of molecular sciences. 21, 17, p. 1-16 16 p., 6077.
Research output: Contribution to journal › Article › peer-review

Open Access
Dicoumarol suppresses HMGA2-mediated oncogenic capacities and inhibits cell proliferation by inducing apoptosis in colon cancer
Chen, C. H., Hsieh, Y. C., Yang, P. M., Liu, Y. R. & Cho, E. C., 2020, In : Biochemical and Biophysical Research Communications.
Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus)
Functional Redox Proteomics Reveal That Salvia miltiorrhiza Aqueous Extract Alleviates Adriamycin-Induced Cardiomyopathy via Inhibiting ROS-Dependent Apoptosis
Hung, Y. C., Wang, P. W., Lin, T. Y., Yang, P. M., You, J. S. & Pan, T. L., 2020, In : Oxidative Medicine and Cellular Longevity. 2020, p. 5136934 5136934.
Research output: Contribution to journal › Article › peer-review

Open Access
Overexpression of miR-21-5p in colorectal cancer cells promotes self-assembly of E-cadherin-dependent multicellular tumor spheroids
Li, A. & Yang, P. M., Aug 1 2020, In : Tissue and Cell. 65, 101365.
Research output: Contribution to journal › Article › peer-review